Search

Your search keyword '"leukemia-associated antigens"' showing total 24 results

Search Constraints

Start Over You searched for: Descriptor "leukemia-associated antigens" Remove constraint Descriptor: "leukemia-associated antigens"
24 results on '"leukemia-associated antigens"'

Search Results

1. Blast-Derived Small Extracellular Vesicles in the Plasma of Patients with Acute Myeloid Leukemia Predict Responses to Chemotherapy.

2. A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells.

3. Blast-Derived Small Extracellular Vesicles in the Plasma of Patients with Acute Myeloid Leukemia Predict Responses to Chemotherapy

4. A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells

5. Increasing Role of Targeted Immunotherapies in the Treatment of AML.

6. Increasing Role of Targeted Immunotherapies in the Treatment of AML

8. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.

9. Biological therapy and the immune system in patients with chronic myeloid leukemia.

10. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.

11. Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy.

12. Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.

13. Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.

14. Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis

15. Serological identification of immunogenic antigens in acute monocytic leukemia

16. Immuntherapeutische Ansätze zur Behandlung von Leukämien.

20. Can increased immunogenicity in chronic myeloid leukemia improve outcomes?

21. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein

22. FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes

Catalog

Books, media, physical & digital resources